{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:06:40Z","timestamp":1792274800807,"version":"4.4.0"},"reference-count":228,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008793","name":"Universidad del Rosario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jaut.2019.04.021","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T12:20:55Z","timestamp":1557318055000},"page":"8-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease"],"prefix":"10.1016","volume":"102","author":[{"given":"Yhojan","family":"Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Vatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Ram\u00edrez-Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Mancera-P\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Manuel","family":"Anaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2019.04.021_bib1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.mayocp.2018.03.026","article-title":"History, diagnosis, and management of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"93","author":"Dyck","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jaut.2019.04.021_bib2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1212\/WNL.0000000000003504","article-title":"A population-based epidemiologic study of adult neuromuscular disease in the Republic of Ireland","volume":"88","author":"Lefter","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ene.12190","article-title":"Epidemiology of chronic inflammatory neuropathies in southeast England","volume":"21","author":"Mahdi-Rogers","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib4","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/WCO.0000000000000481","article-title":"Chronic inflammatory demyelinating polyneuropathy","volume":"30","author":"Lewis","year":"2017","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/mus.20391","article-title":"Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment","volume":"32","author":"Jann","year":"2005","journal-title":"Muscle Nerve"},{"issue":"Pt 6","key":"10.1016\/j.jaut.2019.04.021_bib6","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/brain\/110.6.1617","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases","volume":"110","author":"McCombe","year":"1987","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.021_bib7","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/1531-8249(199912)46:6<910::AID-ANA14>3.0.CO;2-2","article-title":"Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia","volume":"46","author":"McLeod","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib8","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1136\/jnnp.2007.114868","article-title":"Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy","volume":"78","author":"Chio","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib9","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1136\/jnnp.2007.128132","article-title":"Refractory peripheral neuropathy study group of Japan. Prevalence and incidence rates of chronic inflammatory demyelinating polyneuropathy in the Japanese population","volume":"79","author":"Iijima","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jnnp.66.5.677","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England","volume":"66","author":"Lunn","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1468-1331.2001.00187.x","article-title":"Chronic polyneuropathies in Vest-Agder, Norway","volume":"8","author":"Mygland","year":"2001","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib12","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1136\/jnnp.2007.128132","article-title":"Prevalence and incidence rates of chronic inflammatory demyelinating polyneuropathy in the Japanese population","volume":"79","author":"Iijima","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1440-1819.1995.tb02223.x","article-title":"Epidemiology of inflammatory neurological and inflammatory neuromuscular diseases in Tottori Prefecture, Japan","volume":"49","author":"Kusumi","year":"1995","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jaut.2019.04.021_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1529-8027.2000.00014.x","article-title":"Chronic inflammatory demyelinating polyneuropathy caused by HIV infection in a patient with asymptomatic CMT 1A","volume":"5","author":"Rajabally","year":"2000","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jaut.2019.04.021_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/01.WNL.0000131899.33969.E5","article-title":"Improvement of a CIDP associated with hepatitis C virus infection using antiviral therapy","volume":"63","author":"Corcia","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejim.2006.09.021","article-title":"Chronic inflammatory demyelinating polyneuropathy in an HCV-related cirrhotic patient with acute hepatitis B superinfection","volume":"18","author":"Ersoz","year":"2007","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jaut.2019.04.021_bib17","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1468-1331.2006.01416.x","article-title":"Polyneuropathy with demyelinating features in mixed cryoglobulinemia with hepatitis C virus infection","volume":"13","author":"Boukhris","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/mus.26182","article-title":"Remission of chronic inflammatory demyelinating polyneuropathy after hepatitis C virus eradication with sofosbuvir and ledipasvir therapy","author":"Tsuzaki","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2019.04.021_bib19","doi-asserted-by":"crossref","first-page":"P72","DOI":"10.1186\/1471-2334-14-S3-P72","article-title":"IRIS manifesting as chronic inflammatory demyelinating polyneuropathy in HIV","volume":"14","author":"Reghukumar","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jaut.2019.04.021_bib20","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/ndt\/14.9.2228","article-title":"Inflammatory demyelinating polyneuropathy in a kidney transplant patient with cytomegalovirus infection","volume":"14","author":"de Maar","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jaut.2019.04.021_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2005.08.013","article-title":"Concomitant chronic inflammatory demyelinating polyneuropathy and myasthenia gravis following cytomegalovirus infection","volume":"240","author":"Mori","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2019.04.021_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jneuroim.2009.11.003","article-title":"Dysregulated Epstein-Barr virus infection in patients with CIDP","volume":"218","author":"Lunemann","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib23","article-title":"Acute-onset chronic inflammatory demyelinating polyneuropathy in hantavirus and hepatitis B virus coinfection: a case report","volume":"95","author":"Lim","year":"2016","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2019.04.021_bib24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/jnnp.53.4.358-a","article-title":"Chronic polyradiculoneuropathy associated with human T-cell lymphotropic virus type I infection","volume":"53","author":"Arakawa","year":"1990","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib25","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/jnnp.68.6.797","article-title":"Chronic inflammatory demyelinating polyneuropathy as a complication of cat scratch disease","volume":"68","author":"McNeill","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib26","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1136\/jnnp-2017-317346","article-title":"Acute-onset chronic inflammatory demyelinating polyneuropathy after Zika virus infection","volume":"89","author":"Leonhard","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-5728(96)00189-0","article-title":"Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"73","author":"Melendez-Vasquez","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1085-9489.2004.009208.x","article-title":"Chronic inflammatory demyelinating polyneuropathy after Campylobacter jejuni infection mimicking vasculitic mononeuritis multiplex in a diabetic","volume":"9","author":"Rajabally","year":"2004","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jaut.2019.04.021_bib29","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1111\/j.1468-1331.2007.01844.x","article-title":"Chronic inflammatory demyelinating polyneuropathy after Mycoplasma pneumoniae infection","volume":"14","author":"Rajabally","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib30","first-page":"585","article-title":"A pathogenic study of chronic inflammatory demyelinating polyradiculoneuropathy in a patient with hepatitis B infection","volume":"43","author":"Inoue","year":"1994","journal-title":"Arerugi"},{"key":"10.1016\/j.jaut.2019.04.021_bib31","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1744-9987.1998.tb00128.x","article-title":"Prominent effect of immunoadsorption plasmapheresis therapy in a patient with chronic inflammatory demyelinating polyneuropathy associated with hepatitis B infection","volume":"2","author":"Inoue","year":"1998","journal-title":"Ther. Apher."},{"key":"10.1016\/j.jaut.2019.04.021_bib32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11481-015-9607-z","article-title":"Dramatic improvement of chronic inflammatory demyelinating polyneuropathy through tenofovir treatment in a patient infected with hepatitis B virus","volume":"10","author":"Aktas","year":"2015","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.jaut.2019.04.021_bib33","first-page":"286","article-title":"Predominant upper limb chronic demyelinating polyneuropathy associated with HBV infection","volume":"12","author":"Lupescu","year":"2017","journal-title":"Maedica (Buchar)."},{"key":"10.1016\/j.jaut.2019.04.021_bib34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/cmi.2017.142","article-title":"Guillain-Barre syndrome, transverse myelitis and infectious diseases","volume":"15","author":"Rodriguez","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2008.03834.x","article-title":"The role of infections in autoimmune disease","volume":"155","author":"Ercolini","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ajmg.10725","article-title":"Family with inflammatory demyelinating polyneuropathy and the HNPP 17p12 deletion","volume":"113","author":"Korn-Lubetzki","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.jaut.2019.04.021_bib37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.410040317","article-title":"HLA antigens in the Landry-Guillain-Barre syndrome and chronic relapsing polyneuritis","volume":"4","author":"Stewart","year":"1978","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib38","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1073\/pnas.0807319106","article-title":"Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy","volume":"106","author":"Tackenberg","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2019.04.021_bib39","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jneuroim.2008.04.003","article-title":"Susceptibility to chronic inflammatory demyelinating polyradiculoneuropathy is associated to polymorphic GA repeat in the SH2D2A gene","volume":"197","author":"Notturno","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib40","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.410180417","article-title":"Alpha-1 antitrypsin phenotypes in demyelinating disease: an association between demyelinating disease and the allele PiM3","volume":"18","author":"McCombe","year":"1985","journal-title":"Ann. Neurol."},{"issue":"Suppl 1","key":"10.1016\/j.jaut.2019.04.021_bib41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1529-8027.2011.00308.x","article-title":"Polymorphism of transient axonal glycoprotein-1 in chronic inflammatory demyelinating polyneuropathy","volume":"16","author":"Iijima","year":"2011","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jaut.2019.04.021_bib42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/blood-2012-07-441857","article-title":"CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy","volume":"121","author":"Nevo","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2019.04.021_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-0029-1237720","article-title":"Charcot-Marie-Tooth (CMT) disease 1A with superimposed inflammatory polyneuropathy in children","volume":"40","author":"Desurkar","year":"2009","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.jaut.2019.04.021_bib44","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/jnnp.42.2.184","article-title":"HLA antigens in chronic relapsing idiopathic inflammatory polyneuropathy","volume":"42","author":"Adams","year":"1979","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-5728(90)90064-T","article-title":"Major histocompatibility complex class I and class II polymorphism in chronic idiopathic demyelinating polyradiculoneuropathy","volume":"27","author":"Vaughan","year":"1990","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib46","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ana.410260619","article-title":"Gm haplotypes in inflammatory demyelinating polyneuropathies","volume":"26","author":"Feeney","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib47","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.transci.2013.07.024","article-title":"Association of HLA-DR\/DQ polymorphism with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in Tunisian patients","volume":"49","author":"Mrad","year":"2013","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.jaut.2019.04.021_bib48","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-5728(91)90005-R","article-title":"HLA antigens in patients with chronic inflammatory demyelinating polyneuropathy","volume":"32","author":"van Doorn","year":"1991","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib49","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jneuroim.2006.07.017","article-title":"Studies of HLA associations in male and female patients with Guillain-Barre syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)","volume":"180","author":"McCombe","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/jns5.12061","article-title":"HLA-DRB1* alleles genotyping in chronic inflammatory demyelinating polyneuropathy in Greek patients","volume":"19","author":"Anagnostouli","year":"2014","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jaut.2019.04.021_bib51","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12974-017-0996-1","article-title":"Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15","volume":"14","author":"Martinez-Martinez","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jaut.2019.04.021_bib52","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1600-065X.2009.00829.x","article-title":"The T-cell-specific adapter protein family: TSAd, ALX, and SH2D4A\/SH2D4B","volume":"232","author":"Lapinski","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2019.04.021_bib53","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.imlet.2004.10.019","article-title":"The emerging role of the T cell-specific adaptor (TSAd) protein as an autoimmune disease-regulator in mouse and man","volume":"97","author":"Marti","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jaut.2019.04.021_bib54","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1212\/WNL.34.10.1375","article-title":"Chronic demyelinating polyneuropathy in systemic lupus erythematosus","volume":"34","author":"Rechthand","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib55","doi-asserted-by":"crossref","first-page":"980","DOI":"10.12659\/AJCR.903541","article-title":"Chronic inflammatory demyelinating polyneuropathy (CIDP): an uncommon manifestation of systemic lupus erythematosus (SLE)","volume":"18","author":"Abraham","year":"2017","journal-title":"Am. J. Case Rep."},{"key":"10.1016\/j.jaut.2019.04.021_bib56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/jns.12218","article-title":"Drug-induced cutaneous lupus erythematosus after immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a case series","volume":"22","author":"Adrichem","year":"2017","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jaut.2019.04.021_bib57","first-page":"439","article-title":"Ocular myasthenia gravis and chronic inflammatory polyradiculoneuropathy","volume":"86","author":"Weinreb","year":"1986","journal-title":"N. Y. State J. Med."},{"key":"10.1016\/j.jaut.2019.04.021_bib58","first-page":"1059","article-title":"Concurrent myasthenia gravis and chronic inflammatory demyelinating polyneuropathy","volume":"19","author":"Patwa","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2019.04.021_bib59","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-2007-973544","article-title":"A case of myasthenia gravis in childhood associated with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"29","author":"Kimura","year":"1998","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.jaut.2019.04.021_bib60","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/088307389901400715","article-title":"Chronic inflammatory demyelinating polyneuropathy and myasthenia gravis","volume":"14","author":"Tam","year":"1999","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib61","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/jnnp.2009.174888","article-title":"Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis","volume":"82","author":"Sadnicka","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12883-018-1120-6","article-title":"CIDP, myasthenia gravis, and membranous glomerulonephritis - three autoimmune disorders in one patient: a case report","volume":"18","author":"Bolz","year":"2018","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib63","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/00207454.2017.1398160","article-title":"Myasthenia gravis and chronic inflammatory demyelinating polyneuropathy in the same patient - a case report","volume":"128","author":"Quan","year":"2018","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.jaut.2019.04.021_bib64","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/WNL.37.8.1291","article-title":"Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"37","author":"Mendell","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib65","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000116042","article-title":"Systemic lupus erythematosus presenting with recurrent acute demyelinating polyneuropathy","volume":"25","author":"Millette","year":"1986","journal-title":"Eur. Neurol."},{"issue":"Pt 1","key":"10.1016\/j.jaut.2019.04.021_bib66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/brain\/110.1.53","article-title":"Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination","volume":"110","author":"Thomas","year":"1987","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.021_bib67","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/jnnp.53.9.789","article-title":"Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: a clinical, electrophysiological and magnetic resonance imaging study","volume":"53","author":"Ormerod","year":"1990","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib68","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0960-8966(02)00214-6","article-title":"Childhood chronic inflammatory demyelinating polyneuropathy with central nervous system demyelination resembling multiple sclerosis","volume":"13","author":"Rodriguez-Casero","year":"2003","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jaut.2019.04.021_bib69","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2169\/internalmedicine.44.68","article-title":"Exacerbation of chronic inflammatory demyelinating polyradiculoneuropathy during interferonbeta-1b therapy in a patient with childhood-onset multiple sclerosis","volume":"44","author":"Matsuse","year":"2005","journal-title":"Intern. Med."},{"key":"10.1016\/j.jaut.2019.04.021_bib70","first-page":"58","article-title":"Spreading of autoimmunity from central to peripheral myelin: two cases of clinical association between multiple sclerosis and chronic inflammatory demyelinating polyneuropathy","volume":"27","author":"Falcone","year":"2006","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"10.1016\/j.jaut.2019.04.021_bib71","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/CND.0b013e31816f18e3","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis","volume":"9","author":"Sharma","year":"2008","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"10.1016\/j.jaut.2019.04.021_bib72","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy occurring after autologous haematopoietic stem cell transplantation for multiple sclerosis","volume":"2","author":"Simonsen","year":"2016","journal-title":"Mult. Scler. J. - Exp. Transl. Clin."},{"key":"10.1016\/j.jaut.2019.04.021_bib73","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4103\/0028-3886.82754","article-title":"Sjogren's syndrome with chronic inflammatory demyelinating polyneuropathy","volume":"59","author":"Lin","year":"2011","journal-title":"Neurol. India"},{"key":"10.1016\/j.jaut.2019.04.021_bib74","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/mus.23339","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with alopecia totalis and Sjogren syndrome","volume":"45","author":"Sanvito","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2019.04.021_bib75","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/bmt.2013.18","article-title":"Sjogren's syndrome associated chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) treated with autologous and subsequently allogeneic haematopoietic SCT (HSCT)","volume":"48","author":"Bregante","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jaut.2019.04.021_bib76","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1600-0404.1991.tb03971.x","article-title":"Serum antibodies to GM1 and GM3-gangliosides in systemic lupus erythematosus with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"83","author":"Sindern","year":"1991","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jaut.2019.04.021_bib77","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/mus.21138","article-title":"Early neurophysiological evolution of chronic inflammatory demyelinating polyneuropathy in a patient with Hashimoto's thyroiditis","volume":"38","author":"Bairactaris","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2019.04.021_bib78","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1017\/S0317167100007186","article-title":"CIDP, Hashimoto's thyroiditis and nephropathy: autoimmune syndrome complex?","volume":"36","author":"Raghavendra","year":"2009","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2019.04.021_bib79","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000117120","article-title":"Chronic inflammatory demyelinating polyneuropathy in patient with rheumatoid arthritis","volume":"35","author":"Zappia","year":"1995","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib80","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/mus.21584","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists","volume":"41","author":"Alshekhlee","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2019.04.021_bib81","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1399-543X.2005.00130.x","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy in two children with type 1 diabetes mellitus","volume":"6","author":"Fudge","year":"2005","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.jaut.2019.04.021_bib82","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1590\/S0004-282X2009000200029","article-title":"Chronic inflammatory demyelinating polyneuropathy in an adolescent with type 1 diabetes mellitus","volume":"67","author":"Alves","year":"2009","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.jaut.2019.04.021_bib83","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1212\/WNL.46.3.822","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with malignant melanoma","volume":"46","author":"Bird","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib84","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11060-009-9848-x","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with metastatic malignant melanoma of unknown primary origin","volume":"94","author":"Palma","year":"2009","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.jaut.2019.04.021_bib85","first-page":"91","article-title":"Chronic inflammatory demyelinating polyradiculoneurophathy and Graves' disease in an adolescent with Crohn's disease","volume":"29","author":"Gomez","year":"1999","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2019.04.021_bib86","first-page":"1799","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with primary biliary cirrhosis","volume":"20","author":"Murata","year":"2013","journal-title":"J. Clin. Neurosci. Off. J. Neurosurg. Soc. Australas."},{"key":"10.1016\/j.jaut.2019.04.021_bib87","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMcpc020031","article-title":"Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 6-2003. A nine-year-old girl with progressive weakness and areflexia","volume":"348","author":"Sander","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.04.021_bib88","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.pediatrneurol.2014.04.017","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with autoimmune hepatitis","volume":"51","author":"Domingos","year":"2014","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib89","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.semarthrit.2005.08.008","article-title":"Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome","volume":"35","author":"Vina","year":"2005","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2019.04.021_bib90","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00296-009-1008-2","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy in a boy with systemic lupus erythematosus","volume":"30","author":"Zoilo","year":"2010","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2019.04.021_bib91","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/mus.21543","article-title":"Acute-onset chronic inflammatory demyelinating polyneuropathy with cranial nerve involvement, dysautonomia, respiratory failure, and autoantibodies","volume":"41","author":"Hantson","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2019.04.021_bib92","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1007\/s00296-011-2130-5","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus and good outcome with rituximab treatment","volume":"32","author":"Sanz","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2019.04.021_bib93","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1177\/0961203312440346","article-title":"Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide","volume":"21","author":"Jasmin","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2019.04.021_bib94","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/ard.49.3.147","article-title":"Association between HLA-DR antigens and rheumatoid arthritis in Arabs.","volume":"49","author":"Sattar","year":"1990","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.04.021_bib95","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.2012.01134.x","article-title":"The genetics of multiple sclerosis: an up-to-date review","volume":"248","author":"Gourraud","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2019.04.021_bib96","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1600-0404.1994.tb02731.x","article-title":"Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy","volume":"90","author":"Tola","year":"1994","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jaut.2019.04.021_bib97","first-page":"3","article-title":"HLA-B8 in caucasian patients with systemic lupus erythematosus","volume":"7","author":"Scherak","year":"1978","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jaut.2019.04.021_bib98","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJM197704212961602","article-title":"Sjogren's syndrome association with HLA-Dw3","volume":"296","author":"Chused","year":"1977","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.04.021_bib99","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0022-510X(76)90213-6","article-title":"Chronic relapsing polyneuritis","volume":"27","author":"Prineas","year":"1976","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2019.04.021_bib100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-5728(86)90059-7","article-title":"Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy","volume":"13","author":"Pollard","year":"1986","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib101","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1212\/WNL.53.4.837","article-title":"The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy","volume":"53","author":"Bosboom","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib102","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1212\/01.wnl.0000188879.19900.b7","article-title":"Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP","volume":"65","author":"Sommer","year":"2005","journal-title":"Neurology"},{"issue":"Pt 4","key":"10.1016\/j.jaut.2019.04.021_bib103","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/brain\/118.4.857","article-title":"Intraneural activated T cells cause focal breakdown of the blood-nerve barrier","volume":"118","author":"Spies","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.021_bib104","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ana.410370409","article-title":"Activated T cells of nonneural specificity open the blood-nerve barrier to circulating antibody","volume":"37","author":"Pollard","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib105","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/eji.1830220721","article-title":"Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines","volume":"22","author":"Linington","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib106","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9","article-title":"Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy","volume":"19","author":"Schmidt","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2019.04.021_bib107","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1179\/1743132812Y.0000000074","article-title":"Proinflammatory cytokines in serum and cerebrospinal fluid of CIDP patients","volume":"34","author":"Rentzos","year":"2012","journal-title":"Neurol. Res."},{"key":"10.1016\/j.jaut.2019.04.021_bib108","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.410300110","article-title":"Serum interleukin-2 concentrations in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis","volume":"30","author":"Hartung","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib109","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(99)00009-X","article-title":"TNF alpha, IFN gamma and IL-2 mRNA expression in CIDP sural nerve biopsies","volume":"163","author":"Mathey","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2019.04.021_bib110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0301-0082(00)00060-5","article-title":"The role of macrophages in immune-mediated damage to the peripheral nervous system","volume":"64","author":"Kiefer","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jaut.2019.04.021_bib111","article-title":"Transcriptome analysis of peripheral blood in chronic inflammatory demyelinating polyradiculoneuropathy patients identifies TNFR1 and TLR pathways in the IVIg response","volume":"95","author":"Richard","year":"2016","journal-title":"Medicine (Baltim.)"},{"issue":"Pt 8","key":"10.1016\/j.jaut.2019.04.021_bib112","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/brain\/123.8.1660","article-title":"Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy","volume":"123","author":"Murata","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.021_bib113","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/jnnp.69.3.362","article-title":"Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies","volume":"69","author":"Kiefer","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib114","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0165-5728(94)00185-Q","article-title":"Increased frequencies of HPRT mutant T lymphocytes in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy: further evidence for a role of T cells in the etiopathogenesis of peripheral demyelinating diseases","volume":"58","author":"Van den Berg","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib115","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/WNL.0b013e318245d250","article-title":"CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"78","author":"Schneider-Hohendorf","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib116","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.0b013e31827debad","article-title":"Recovery of the T-cell repertoire in CIDP by IV immunoglobulins","volume":"80","author":"Mausberg","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib117","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp-2014-309697","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype","volume":"86","author":"Mathey","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib118","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1529-8027.2008.00158.x","article-title":"Impairment of circulating CD4+CD25+ regulatory T cells in patients with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"13","author":"Chi","year":"2008","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jaut.2019.04.021_bib119","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3109\/08916930903140907","article-title":"Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"42","author":"Sanvito","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2019.04.021_bib120","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/(SICI)1097-4598(199912)22:12<1704::AID-MUS13>3.0.CO;2-A","article-title":"The action mechanism of cyclooxygenase-2 inhibitor for treatment of experimental allergic neuritis","volume":"22","author":"Miyamoto","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2019.04.021_bib121","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.neurol.2016.05.006","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: a new animal model for new therapeutic targets","volume":"172","author":"de Seze","year":"2016","journal-title":"Rev. Neurol. (Paris)"},{"issue":"Pt 1","key":"10.1016\/j.jaut.2019.04.021_bib122","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/brain\/114.1.429","article-title":"Chronic relapsing experimental allergic neuritis induced by repeated transfer of P2-protein reactive T cell lines","volume":"114","author":"Lassmann","year":"1991","journal-title":"Brain"},{"issue":"Pt 1","key":"10.1016\/j.jaut.2019.04.021_bib123","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/brain\/121.10.1895","article-title":"Induction of experimental autoimmune neuritis with peripheral myelin protein-22","volume":"121","author":"Gabriel","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.021_bib124","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(99)00250-7","article-title":"Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies","volume":"104","author":"Ritz","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-5728(99)00269-6","article-title":"Anti-PMP22 antibodies in patients with inflammatory neuropathy","volume":"104","author":"Gabriel","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib126","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0165-5728(99)00047-8","article-title":"Effects of cyclosporin A treatment on clinical course and inflammatory cell apoptosis in experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein","volume":"97","author":"McCombe","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib127","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/jnr.10879","article-title":"Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization","volume":"75","author":"Jung","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jaut.2019.04.021_bib128","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0165-5728(01)00307-1","article-title":"Investigation of serum response to PMP22, connexin 32 and P(0) in inflammatory neuropathies","volume":"116","author":"Kwa","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib129","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/jnnp.2008.159798","article-title":"Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"80","author":"Sanvito","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0165-5728(93)90255-W","article-title":"Antibody responses to P0 and P2 myelin proteins in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy","volume":"46","author":"Khalili-Shirazi","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib131","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jnnp.2006.106617","article-title":"Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy","volume":"78","author":"Inglis","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib132","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1085-9489.2005.0010207.x","article-title":"Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"10","author":"Allen","year":"2005","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jaut.2019.04.021_bib133","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ana.1129","article-title":"P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Yan","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib134","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00019052-200210000-00013","article-title":"Animal models of immune-mediated neuropathies","volume":"15","author":"Maurer","year":"2002","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/jaut.1998.0259","article-title":"Nasal administration of recombinant rat IL-4 ameliorates ongoing experimental autoimmune neuritis and inhibits demyelination","volume":"12","author":"Deretzi","year":"1999","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.04.021_bib136","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0165-5728(88)90101-4","article-title":"Immune reactive C3d on the surface of myelin sheaths in neuropathy","volume":"18","author":"Hays","year":"1988","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib137","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archneur.1980.00500590061010","article-title":"Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy","volume":"37","author":"Dalakas","year":"1980","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(84)90136-9","article-title":"Chronic inflammatory polyneuropathy. Reduction of nerve conduction velocities in monkeys by systemic passive transfer of immunoglobulin G","volume":"66","author":"Heininger","year":"1984","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2019.04.021_bib139","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/1531-8249(200006)47:6<765::AID-ANA9>3.0.CO;2-8","article-title":"Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients","volume":"47","author":"Yan","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0022-510X(87)90235-8","article-title":"P0 myelin protein produces experimental allergic neuritis in Lewis rats","volume":"79","author":"Milner","year":"1987","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2019.04.021_bib141","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/mus.880080607","article-title":"Endoneurial injection of antisera to myelin antigens","volume":"8","author":"Hughes","year":"1985","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2019.04.021_bib142","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/WNL.0b013e3182a1aa9c","article-title":"Anti-neurofascin antibody in patients with combined central and peripheral demyelination","volume":"81","author":"Kawamura","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib143","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","article-title":"Neurofascin as a target for autoantibodies in peripheral neuropathies","volume":"79","author":"Ng","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib144","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","article-title":"Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg","volume":"82","author":"Querol","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib145","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.neuron.2005.10.019","article-title":"Neurofascins are required to establish axonal domains for saltatory conduction","volume":"48","author":"Sherman","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.jaut.2019.04.021_bib146","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1529-8027.2012.00372.x","article-title":"Nodal proteins are target antigens in Guillain-Barre syndrome","volume":"17","author":"Devaux","year":"2012","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jaut.2019.04.021_bib147","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/brain\/aww062","article-title":"Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects","volume":"139","author":"Manso","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.021_bib148","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0896-6273(01)00296-3","article-title":"Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve","volume":"30","author":"Boyle","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.jaut.2019.04.021_bib149","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib150","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1093\/brain\/aww189","article-title":"Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy","volume":"139","author":"Doppler","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.021_bib151","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1113\/jphysiol.1949.sp004335","article-title":"Evidence for saltatory conduction in peripheral myelinated nerve fibres","volume":"108","author":"Huxley","year":"1949","journal-title":"J. Physiol."},{"key":"10.1016\/j.jaut.2019.04.021_bib152","article-title":"The nodes of ranvier: molecular assembly and maintenance","volume":"8","author":"Rasband","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jaut.2019.04.021_bib153","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1007\/BF00323315","article-title":"On the fine structure of the adrenal medulla of the hedgehog (Erinaceus europaeus L.)","volume":"64","author":"Bargmann","year":"1964","journal-title":"Z. Zellforsch. Mikrosk. Anat."},{"key":"10.1016\/j.jaut.2019.04.021_bib154","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0960-9822(01)00680-7","article-title":"Neurofascin is a glial receptor for the paranodin\/Caspr-contactin axonal complex at the axoglial junction","volume":"12","author":"Charles","year":"2002","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jaut.2019.04.021_bib155","doi-asserted-by":"crossref","first-page":"7907","DOI":"10.1074\/jbc.M113.528489","article-title":"Specific contactin N-glycans are implicated in neurofascin binding and autoimmune targeting in peripheral neuropathies","volume":"289","author":"Labasque","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"Suppl 1","key":"10.1016\/j.jaut.2019.04.021_bib156","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1007\/s10875-010-9398-1","article-title":"Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathy","volume":"30","author":"Tackenberg","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib157","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/brain\/awv054","article-title":"Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia","volume":"138","author":"Miura","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.021_bib158","series-title":"Antineurofascin Antibodies Are Present in Patients with Peripheral Demyelinating Neuropathies and Mediate Changes in Nerve Conduction in Animals","author":"Yan","year":"2010"},{"key":"10.1016\/j.jaut.2019.04.021_bib159","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2014.09.012","article-title":"Antibodies to neurofascin exacerbate adoptive transfer experimental autoimmune neuritis","volume":"277","author":"Yan","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib160","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","article-title":"Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy","volume":"86","author":"Devaux","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib161","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/acn3.248","article-title":"Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy","volume":"2","author":"Ogata","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib162","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/jnnp-2016-314895","article-title":"Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies","volume":"88","author":"Koike","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib163","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.nmd.2016.10.008","article-title":"Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies","volume":"27","author":"Vallat","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jaut.2019.04.021_bib164","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014533","article-title":"Nodes of ranvier and paranodes in chronic acquired neuropathies","volume":"6","author":"Cifuentes-Diaz","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.04.021_bib165","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/jns5.12023","article-title":"Disruption of nodal architecture in skin biopsies of patients with demyelinating neuropathies","volume":"18","author":"Doppler","year":"2013","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jaut.2019.04.021_bib166","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrn1701","article-title":"The development of nociceptive circuits","volume":"6","author":"Fitzgerald","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jaut.2019.04.021_bib167","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/brain\/awn281","article-title":"Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis","volume":"132","author":"Lonigro","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.021_bib168","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/cei.12756","article-title":"Regulatory T and B lymphocytes in a spontaneous autoimmune polyneuropathy","volume":"184","author":"Quan","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib169","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/(SICI)1097-4598(199905)22:5<560::AID-MUS2>3.0.CO;2-Q","article-title":"Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome","volume":"22","author":"Saperstein","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2019.04.021_bib170","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","article-title":"European federation of neurological societies\/peripheral nerve society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European federation of neurological Societies and the Periphe","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib171","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.0000000000001833","article-title":"CIDP diagnostic pitfalls and perception of treatment benefit","volume":"85","author":"Allen","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib172","first-page":"125","article-title":"Cerebrospinal fluid findings in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathies","volume":"146","author":"Illes","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib173","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1989.00520440064022","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria","volume":"46","author":"Barohn","year":"1989","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib174","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1136\/jnnp.56.10.1066","article-title":"Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients","volume":"56","author":"Notermans","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib175","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A","article-title":"Clinical spectrum of chronic acquired demyelinating polyneuropathies","volume":"24","author":"Saperstein","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2019.04.021_bib176","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jneuroim.2009.06.012","article-title":"Candidate biomarkers of chronic inflammatory demyelinating polyneuropathy (CIDP): proteome analysis of cerebrospinal fluid","volume":"214","author":"Tumani","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib177","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"41","author":"Cornblath","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib178","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jns.2004.10.001","article-title":"Th1 shift in CIDP versus Th2 shift in vasculitic neuropathy in CSF","volume":"228","author":"Mei","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2019.04.021_bib179","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1529-8027.2010.00294.x","article-title":"Distribution of Th17 cells and Th1 cells in peripheral blood and cerebrospinal fluid in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"15","author":"Chi","year":"2010","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jaut.2019.04.021_bib180","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cyto.2010.05.005","article-title":"The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barre syndrome from chronic inflammatory demyelinating polyneuropathy","volume":"51","author":"Sainaghi","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.jaut.2019.04.021_bib181","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1024532715775","article-title":"Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"23","author":"Press","year":"2003","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib182","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/jnnp.73.3.320","article-title":"Expression of chemokines in cerebrospinal fluid and serum of patients with chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Mahad","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib183","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/brain\/awf070","article-title":"Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10","volume":"125","author":"Kieseier","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.021_bib184","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1212\/WNL.55.12.1828","article-title":"Cystatin C and cathepsin B in CSF from patients with inflammatory neurologic diseases","volume":"55","author":"Nagai","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib185","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jns.2016.01.055","article-title":"Ultrasound of the nerves - an appropriate addition to nerve conduction studies to differentiate paraproteinemic neuropathies","volume":"362","author":"Athanasopoulou","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2019.04.021_bib186","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/mus.24352","article-title":"Triple-stimulation technique improves the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"51","author":"Attarian","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2019.04.021_bib187","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/WNP.0000000000000050","article-title":"Somatosensory evoked potentials in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"31","author":"Salhi","year":"2014","journal-title":"J. Clin. Neurophysiol."},{"key":"10.1016\/j.jaut.2019.04.021_bib188","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.24314","article-title":"Reconstruction magnetic resonance neurography in chronic inflammatory demyelinating polyneuropathy","volume":"77","author":"Shibuya","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib189","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/acn3.275","article-title":"Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy","volume":"3","author":"Stettner","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib190","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids: mechanisms of action in health and disease","volume":"42","author":"Ramamoorthy","year":"2016","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.jaut.2019.04.021_bib191","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/brain\/92.3.589","article-title":"Recurrent and chronic relapsing Guillain-Barre polyneuritis","volume":"92","author":"Thomas","year":"1969","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.021_bib192","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/jnnp.33.1.62","article-title":"Remarkable recovery of a steroid-responsive recurrent polyneuropathy","volume":"33","author":"DeVivo","year":"1970","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib193","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/brain\/81.2.157","article-title":"Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone","volume":"81","author":"Austin","year":"1958","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.021_bib194","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ana.410110205","article-title":"Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment","volume":"11","author":"Dyck","year":"1982","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib195","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/archneur.65.11.1460","article-title":"Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids","volume":"65","author":"Muley","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib196","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/WNL.0b013e31824e8f84","article-title":"Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment","volume":"78","author":"Eftimov","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib197","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clineuro.2014.01.001","article-title":"Treatment of chronic inflammatory demyelinating polyneuropathy with high dose intravenous methylprednisolone monthly for five years: 10-Year follow up","volume":"118","author":"Boru","year":"2014","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jaut.2019.04.021_bib198","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jneuroim.2010.09.015","article-title":"Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies","volume":"231","author":"Lehmann","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"Suppl 4","key":"10.1016\/j.jaut.2019.04.021_bib199","first-page":"S217","article-title":"Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases","volume":"24","author":"Bayry","year":"2003","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"10.1016\/j.jaut.2019.04.021_bib200","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(07)70329-0","article-title":"Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial","volume":"7","author":"Hughes","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib201","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001797.pub3","article-title":"Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Eftimov","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jaut.2019.04.021_bib202","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/BF00868527","article-title":"A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"243","author":"Thompson","year":"1996","journal-title":"J. Neurol."},{"issue":"Pt 4","key":"10.1016\/j.jaut.2019.04.021_bib203","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/119.4.1067","article-title":"Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study","volume":"119","author":"Hahn","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.021_bib204","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/WNL.56.4.445","article-title":"Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy","volume":"56","author":"Mendell","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/jnnp.56.1.36","article-title":"Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study","volume":"56","author":"Vermeulen","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib206","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/ene.12513","article-title":"Subcutaneous immunoglobulin preserves muscle strength in chronic inflammatory demyelinating polyneuropathy","volume":"21","author":"Markvardsen","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib207","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1474-4422(17)30378-2","article-title":"Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"van Schaik","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib208","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/jns.12262","article-title":"Individualized immunoglobulin therapy in chronic immune-mediated peripheral neuropathies","volume":"23","author":"Allen","year":"2018","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jaut.2019.04.021_bib209","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198602203140801","article-title":"Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"314","author":"Dyck","year":"1986","journal-title":"N. Engl. J. Med."},{"issue":"Pt 4","key":"10.1016\/j.jaut.2019.04.021_bib210","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/brain\/119.4.1055","article-title":"Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study","volume":"119","author":"Hahn","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2019.04.021_bib211","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.1088","article-title":"Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Hughes","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib212","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/jnnp-2013-307515","article-title":"Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP","volume":"86","author":"Nobile-Orazio","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib213","first-page":"82","article-title":"Multicentre, randomised, open-label trial to compare efficacy and tolerance of prednisone and IVIG in patients with CIDP on a one year follow up (P7.092)","author":"Camdessanche","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib214","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/ana.410360607","article-title":"A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"36","author":"Dyck","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib215","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1136\/jnnp.45.10.866","article-title":"Chronic idiopathic polyneuropathy treated with azathioprine","volume":"45","author":"Pentland","year":"1982","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib216","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1474-4422(08)70299-0","article-title":"Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study","volume":"8","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib217","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/WNL.53.1.57","article-title":"Randomized trial of interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"53","author":"Hadden","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib218","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1212\/01.WNL.0000134676.05850.C0","article-title":"Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy","volume":"63","author":"Gorson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.04.021_bib219","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/jnnp.2009.188912","article-title":"Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature","volume":"82","author":"Benedetti","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2019.04.021_bib220","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrneurol.2017.84","article-title":"Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications","volume":"13","author":"Querol","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jaut.2019.04.021_bib221","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3389\/fimmu.2018.01029","article-title":"Autoantibodies against the node of ranvier in seropositive chronic inflammatory demyelinating polyneuropathy: diagnostic, pathogenic, and therapeutic relevance","volume":"9","author":"Vural","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2019.04.021_bib222","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1084\/jem.20082113","article-title":"A novel myelin P0-specific T cell receptor transgenic mouse develops a fulminant autoimmune peripheral neuropathy","volume":"206","author":"Louvet","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2019.04.021_bib223","first-page":"CD010369","article-title":"Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews","volume":"1","author":"Oaklander","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jaut.2019.04.021_bib224","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.autrev.2017.02.002","article-title":"Autoimmunity in Guillain-Barre syndrome associated with Zika virus infection and beyond","volume":"16","author":"Pinto-Diaz","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2019.04.021_bib225","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/jns5.12074","article-title":"Genetics of Guillain-Barre syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions","volume":"19","author":"Blum","year":"2014","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jaut.2019.04.021_bib226","first-page":"621","article-title":"Chronic inflammatory polyradiculoneuropathy","volume":"50","author":"Dyck","year":"1975","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jaut.2019.04.021_bib227","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12974-017-1001-8","article-title":"Novel pathomechanisms in inflammatory neuropathies","volume":"14","author":"Schafflick","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jaut.2019.04.021_bib228","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jbspin.2016.11.012","article-title":"The autoimmune tautology. A summary of evidence","volume":"84","author":"Anaya","year":"2017","journal-title":"Jt. Bone Spine."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119300435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119300435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:22:58Z","timestamp":1760257378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841119300435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":228,"alternative-id":["S0896841119300435"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2019.04.021","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2019.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}